Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Metagenomic analysis during capecitabine therapy reveals microbial chemoprotective mechanisms and predicts drug toxicity in colorectal cancer patientsLars E Hillege, Kai R Trepka, Janine Ziemons, et al.
Mbio|May 20, 2025
Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicityLars E Hillege, Kai R Trepka, Benjamin G H Guthrie, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 6, 2024
Open communication between patients and relatives about illness & death in advanced cancer-results of the eQuiPe StudyMichelle Haaksman, Laurien Ham, Linda Brom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2023
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy-A Matched-Pair AnalysisJonathan E Knikman, Tycho A Wilting, Marta Lopez-Yurda, et al.
Nature Communications|June 25, 2020
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trialStefanie de Groot, Rieneke T Lugtenberg, Danielle Cohen, et al.
Journal of Geriatric Oncology|April 3, 2026
Predictors of poor treatment tolerability in older patients receiving fluoropyrimidine-based chemotherapy: A prospective cohort studyJoosje C Baltussen, Jonathan E Knikman, Nienke A de Glas, et al.
Psycho-Oncology|March 17, 2026
Death Anxiety During the Last Year of Life in Patients With Advanced Cancer: Longitudinal Results From the eQuiPe StudyMoyke A J Versluis, Froukje E de Vries, Yvette M van der Linden, et al.
Genome Medicine|August 15, 2024
Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYDJonathan E Knikman, Qinglian Zhai, Carin A T C Lunenburg, et al.
Pageof 3